The importance of temporary mechanical circulatory support for treating acute heart failure
with cardiogenic shock is increasingly recognized, and Impella (Abiomed, Danvers, MA …

Abstract Impella (Abiomed, Danvers, MA, USA) is a recently-innovated (commercially
available from 2017 in Japan) percutaneous left ventricular assist device which is inserted …

The Impella device is a catheter-based miniaturized ventricular assist device. Using a
retrograde femoral artery access, it is placed in the left ventricle across the aortic valve. The …

Introduction Trans-valvular micro-axial flow pumps such as Impella are increasingly utilized
in patients with cardiogenic shock [CS]. A number of different Impella devices are now …

Introduction: Impella is a catheter-based micro-axial flow pump placed across the aortic
valve, and it is currently the only percutaneous left ventricular assist device approved for …

The Impella is a mechanical circulatory support device that supports ventricular function.
Since 2008, when the first Impella device received Food and Drug Administration clearance …

Background: Impella left ventricular assist devices are useful tools for the treatment of
cardiogenic shock. The peri-operative use of Impella in patients with low left ventricular …

Background The treatment of cardiogenic shock with percutaneous mechanical circulatory
support (MCS) is attractive: however, at present it is not clear which is the best strategy, as …

Purpose Impella 5.0 is a short-term left ventricle assist device (LVAD), inserted retrograde
into the left ventricle across the aortic valve through a surgical peripheral access. Impella …

Abstract Introduction The Impella family of devices are short-term mechanical circulatory
support (MCS) pumps that hold promise in treating patients with acute cardiogenic shock …